ANTX
AN2 THERAPEUTICS INC
CUSIP: 037326105
AN2 THERAPEUTICS INC (ANTX) — institutional ownership and SEC 13F holdings data. Source: SEC EDGAR 13F filings.
About
AN2 Therapeutics Inc is a biotechnology company focused on the development and commercialization of therapeutic products, with operations centered on advancing clinical-stage candidates through regulatory review. As a smaller specialty biopharmaceutical firm, it competes in the broader biotech sector and typically relies on external financing, strategic partnerships and successful clinical and regulatory outcomes to progress programs toward commercialization.
Institutional Holders
Source: SEC EDGAR 13F-HR filings from institutional investment managers.
AI Agent
Try asking...